Proteomics characterizing the mechanisms of semaglutide in diabetes mice with cognitive impairment

ABSTRACT: This study aims to investigate the neuroprotective effects of semaglutide in Diabetes-associated cognitive decline (DACD), while also exploring the underlying mechanisms targeting anti-oxidative effects.Methods: This study evaluated the antioxidant properties of semaglutide in a DACD model. To investigate the underlying mechanisms, we employed omics technologies. Proteomic analyses of the cells were conducted to identify the pathways responsible for the observed antioxidant effects.

ORGANISM(S): Mus Musculus

SUBMITTER: Bo Zhang  

PROVIDER: PXD056999 | iProX | Mon Oct 21 00:00:00 GMT+01:00 2024

REPOSITORIES: iProX